TCSS
Showing 1 - 17 of 17
Diabetic Peripheral Neuropathy Type 2 Trial in Wuhan (HUC-MSCs, Lipoic Acid)
Recruiting
- Diabetic Peripheral Neuropathy Type 2
- HUC-MSCs
- Lipoic Acid
-
Wuhan, Hubei, ChinaThe Central Hospital of Wuhan
Aug 16, 2022
Diabetic Peripheral Neuropathic Pain Trial in Hangzhou (Basal therapy+EA, Basal therapy)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- Basal therapy+EA
- Basal therapy
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Sep 21, 2023
Gait Performance in Diabetic Polyneuropathy Patients
Recruiting
- Diabetic Polyneuropathy
-
Giza, EgyptFaculty of physical therapy-Cairo University
Jul 11, 2022
Diabetic Peripheral Neuropathic Pain Trial (Duloxetine Tablets,, Pregabalin Tablets)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- Duloxetine Tablets,
- Pregabalin Tablets
- (no location specified)
Aug 3, 2022
Dry Eye Trial in Xiamen (HBM9036 0.25% Ophthalmic Solution, Placebo)
Recruiting
- Dry Eye
- HBM9036 0.25% Ophthalmic Solution
- Placebo
-
Xiamen, Fujian, ChinaXiamen Eye Center of Xiamen University
Jun 16, 2022
Diabetic Peripheral Neuropathy Type 2 Trial in Beijing (Mudan granule, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathy Type 2
- Mudan granule
- Placebo
-
Beijing, ChinaGuang'anmen Hospital of China Academy of Chinese Medical Science
Jan 13, 2021
Diabetic Peripheral Neuropathy Trial in Hanzhou (infrared thermography (IRT), Basal therapy+EA, Basal therapy)
Recruiting
- Diabetic Peripheral Neuropathy
- infrared thermography (IRT)
- +2 more
-
Hanzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Oct 5, 2023
Diabetic Peripheral Neuropathy, Chinese Medicine, Nerve Conduction Trial in Beijing (LiuWeiLuoBi Granule, Standard medical
Recruiting
- Diabetic Peripheral Neuropathy
- +2 more
- LiuWeiLuoBi Granule
- Standard medical treatment
-
Beijing, Beijing, ChinaYuquan Hospital of Tsinghua University
Apr 6, 2021
Stroke, Ischemic, Coronary Artery Disease, Angina Pectoris, Stable Trial in Beijing (Buqitongluo Granule, Buqitongluo Granule
Recruiting
- Stroke, Ischemic
- +3 more
- Buqitongluo Granule
- +2 more
-
Beijing, Beijing, ChinaDongzhimen Hospital
Mar 29, 2021
Dry Eye Syndromes Trial in Seoul (5% GLH8NDE, Placebo)
Unknown status
- Dry Eye Syndromes
- 5% GLH8NDE
- Placebo
-
Seoul, Gangnam-gu, Korea, Republic ofSamsung Medical Center
Jan 5, 2021
Chronic Neuropathy Following Chemotherapy
Completed
- Peripheral Nervous System Diseases
- Chronic Pain
-
Aarhus, DenmarkDanish Pain Research Center, Aarhus University Hospital
Feb 24, 2021
Diabetic Neuropathy Peripheral Trial in Cairo (Ambroxol Oral Product)
Not yet recruiting
- Diabetic Neuropathy Peripheral
- Ambroxol Oral Product
-
Cairo, EgyptAin Shams university Hospital
Sep 27, 2022
Rhinitis, Allergic, Perennial, House Dust Mite Allergy Trial in Tampa, Montpellier (300 IR, Placebo)
Completed
- Rhinitis, Allergic, Perennial
- House Dust Mite Allergy
- 300 IR
- Placebo
-
Tampa, Florida
- +1 more
Sep 26, 2019
Burnout Syndrome, Nurse's Role Trial in Changsha ("Three good things" therapy, Normal psychological instruction)
Completed
- Burnout Syndrome
- Nurse's Role
- "Three good things" therapy
- Normal psychological instruction
-
Changsha, Hunan, ChinaCentral South University
Aug 23, 2018
Oral Lichen Planus Trial in Faisalabad (Dexamethasone)
Unknown status
- Oral Lichen Planus
-
Faisalābād, Punjab, PakistanThe university of Faisalabad
Jul 29, 2017
Type 2 Diabetes Trial (Tangbi (prescription), Placebo)
Unknown status
- Type 2 Diabetes Mellitus
- Tangbi (prescription)
- Placebo
- (no location specified)
Jan 2, 2017
Diabetic Peripheral Neuropathy, Diabetes, Chinese Herbs Trial (Xuebi formula, )
Unknown status
- Diabetic Peripheral Neuropathy
- +2 more
- Xuebi formula
- placebo
- (no location specified)
Jan 15, 2014